Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lisa Bedell Clive
BERN
Lisa Bedell Clive
Wall Street Analyst
★★★☆☆
#913
on 13Foresight · ranked by our own returns
67%
Success Rate
+10.1%
Average Return
4 of 6 calls profitable · -14.3% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 67% of Lisa Bedell Clive's ratings turned a profit when each position was held for 1 year — averaging +10.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

9 Buy 4 Hold 0 Sell
Lisa's Stock Coverage 21 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
SNN
Smith & Nephew Snats
May 11, 2026 HOLD Buy
+11.8% avg upside
14 analysts
$31.85
5.92% Upside
+2.6%
DE:SHL
Siemens Healthineers AG
Oct 20, 2025 BUY Strong Buy
+51.7% avg upside
22 analysts
$59.00
72.40% Upside
·
NL:PHIA
Koninklijke Philips N.V.
Oct 20, 2025 BUY Buy
+31.4% avg upside
20 analysts
$26.50
12.78% Upside
·
DE:FME
Fresenius Medical Care AG & Co. KGaA
Oct 20, 2025 HOLD Buy
+27.6% avg upside
21 analysts
$54.50
33.94% Upside
·
DE:AFX
Carl Zeiss Meditec
Oct 20, 2025 BUY Hold
+91.0% avg upside
13 analysts
$56.40
126.23% Upside
·
GB:SN
Smith & Nephew
Oct 14, 2025 HOLD Strong Buy
+1305.8% avg upside
15 analysts
$1400.00
24.45% Upside
·
GB:0QBO
Coloplast A/S
Sep 11, 2025 BUY Buy
+87.4% avg upside
16 analysts
$760.00
103.63% Upside
·
FMS
Fresenius Medical Care
Jun 18, 2025 HOLD Buy
+97.2% avg upside
13 analysts
$31.50
33.44% Upside
-20.6%
DVA
DaVita
Jun 18, 2025 HOLD Hold
-23.0% avg upside
17 analysts
$150.00
27.83% Downside
+55.1%
PHG
Koninklijke Philips
Jun 04, 2025 BUY Buy
+31.4% avg upside
13 analysts
$30.30
13.11% Upside
+19.3%
SE:EKTA.B
Elekta AB
Jun 04, 2025 HOLD Sell
+23.4% avg upside
12 analysts
$55.00
13.27% Upside
·
GB:CTEC
ConvaTec
May 23, 2025 BUY Strong Buy
+41.3% avg upside
16 analysts
$300.00
44.94% Upside
·
DE:FRE
Fresenius SE & Co. KGaA
Apr 07, 2025 HOLD Strong Buy
+29.4% avg upside
19 analysts
$50.00
26.22% Upside
·
EKTAY
Elekta AB
Apr 11, 2024 SELL Sell
2 analysts
·
CH:SOON
Sonova Holding AG
May 17, 2023 SELL Sell
+14.3% avg upside
17 analysts
$220.00
13.84% Upside
·
GB:0K9P
GN Store Nord
Dec 21, 2021 HOLD Hold
+169.4% avg upside
13 analysts
$440.00
396.50% Upside
·
AU:COH
Cochlear
Dec 21, 2021 BUY Hold
+49.9% avg upside
15 analysts
$250.00
111.69% Upside
·
CH:STMN
Straumann Holding AG
Dec 21, 2021 BUY Buy
+19.9% avg upside
13 analysts
$215.00
105.40% Upside
·
IT:AMP
Amplifon S.p.A.
Dec 21, 2021 HOLD Hold
+155.3% avg upside
12 analysts
$40.00
291.33% Upside
·
FSNUY
Fresenius SE & Co
Mar 24, 2020 BUY Strong Buy
-11.2% avg upside
6 analysts
$10.00
11.22% Downside
+24.3%
COST
Costco
Nov 17, 2014 SELL Strong Buy
-9.2% avg upside
50 analysts
$115.00
87.83% Downside
-19.8%
🔒 16 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Lisa Bedell Clive — Frequently Asked Questions
How accurate are Lisa Bedell Clive's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Lisa's ratings were profitable over a one-year hold, with an average return of +10.1% per rating, or -14.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Lisa ranked on 13Foresight?
Lisa Bedell Clive is currently ranked #913 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lisa cover?
Lisa most recently has ratings on SNN, DE:SHL, NL:PHIA, DE:FME, DE:AFX, GB:SN, GB:0QBO, FMS, DVA, PHG, SE:EKTA.B, GB:CTEC and 9 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.